Grimley P M, Ray S, Kostianovsky M, Rupp B, Kang Y H, Feldman D
F. Edward Hebert Medical School, Bethesda, MD.
Scanning Microsc. 1988 Dec;2(4):2141-51.
Human alpha interferons (IFN-a) cause a reorganization of internal cell membranes into tubuloreticular inclusions (TRI). Morphogenesis and cytochemistry indicate a pre-Golgi intracisternal origin from the endoplasmic reticulum. Clinically, TRI formation in human blood mononuclear cells correlates with systemic IFN-a treatment or with endogenous overproduction of IFN-a in viral or autoimmune diseases (e.g., rubella syndrome, AIDS, systemic lupus erythematosus). In vitro, TRI formation can be produced by treatment of Daudi lymphoblasts or vascular endothelial cells with IFN-a, and is blocked by actinomycin-D. In Daudi lymphoblasts or vascular endothelial cell cultures, TRI formation parallels induction of 2'-5' A synthetase, inhibition of thymidine kinase and growth inhibition; however, heavy water treatment of Daudi cells prevented TRI formation while induction of 2'-5' A synthetase and growth inhibition persisted. TRI formation was dissociated from IFN-a antiproliferative activity in a mutant clone of Daudi lymphoblasts. Decreased glycoprotein biosynthesis and increased phospholipid biosynthesis may accompany progressive TRI accumulation.
人α干扰素(IFN-α)可导致细胞内膜重新组织形成管状网状包涵体(TRI)。形态发生学和细胞化学表明其起源于内质网的高尔基前池内。在临床上,人血单核细胞中TRI的形成与全身性IFN-α治疗或与病毒或自身免疫性疾病(如风疹综合征、艾滋病、系统性红斑狼疮)中IFN-α的内源性过量产生相关。在体外,用IFN-α处理Daudi淋巴母细胞或血管内皮细胞可产生TRI形成,且放线菌素-D可阻断该过程。在Daudi淋巴母细胞或血管内皮细胞培养物中,TRI形成与2'-5'A合成酶的诱导、胸苷激酶的抑制和生长抑制平行;然而,用重水处理Daudi细胞可阻止TRI形成,而2'-5'A合成酶的诱导和生长抑制仍持续存在。在Daudi淋巴母细胞的一个突变克隆中,TRI形成与IFN-α的抗增殖活性分离。随着TRI的逐渐积累,糖蛋白生物合成减少,磷脂生物合成增加。